| Literature DB >> 35414895 |
Daniel J Breiner1, Matthew R Whalen1,2, Amy M Worthington1.
Abstract
The strategic allocation of resources into immunity poses a unique challenge for individuals, where infection at different stages of development may result in unique trade-offs with concurrent physiological processes or future fitness-enhancing traits. Here, we experimentally induced an immune challenge in female Gryllus firmus crickets to test whether illness at discrete life stages differentially impacts fitness. We injected heat-killed Serratia marcescens bacteria into antepenultimate juveniles, penultimate juveniles, sexually immature adults, and sexually mature adults, and then measured body growth, instar duration, mating rate, viability of stored sperm, egg production, oviposition rate, and egg viability. Immune activation significantly impacted reproductive traits, where females that were immune challenged as adults had decreased mating success and decreased egg viability compared to healthy individuals or females that were immune challenged as juveniles. Although there was no effect of an immune challenge on the other traits measured, the stress of handling resulted in reduced mass gain and smaller adult body size in females from the juvenile treatments, and females in the adult treatments suffered from reduced viability of sperm stored within their spermatheca. In summary, we found that an immune challenge does have negative impacts on reproduction, but also that even minor acute stressors can have significant impacts on fitness-enhancing traits. These findings highlight that the factors affecting fitness can be complex and at times unpredictable, and that the consequences of illness are specific to when during an individual's life an immune challenge is induced.Entities:
Keywords: Gryllus; cricket; development; fecundity; fitness; immunity; life history trade‐offs; reproduction
Year: 2022 PMID: 35414895 PMCID: PMC8986548 DOI: 10.1002/ece3.8774
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Summarized unreduced models for individuals treated across all four developmental stages
| Fixed effect | Mating success | Total eggs | Eggs laid | Mass gained | Pronotum gain | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| χ2 |
| χ2 |
| χ2 |
|
|
|
|
| |
| Time | 32.4 | <.001 | 8.01 | <.05 | 1.21 | .750 | 3.40 | <.5 | 3.21 | <.05 |
| Treatment | 4.41 | <.05 | 1.58 | .209 | 0.17 | .680 | 0.176 | .67 | 0.180 | .671 |
| Time × Treatment | 13.6 | <.01 | 4.05 | .256 | 0.72 | .869 | 1.12 | .34 | 3.73 | <.05 |
FIGURE 1Pairwise comparisons for body measurements across all groups that received their treatment at the developmental stages listed: (a) mass gained during penultimate instar, and (b) pronotum length gain during penultimate instar. Control individuals are shown in yellow, while immune‐challenged individuals are shown in purple
FIGURE 2Mating success and sperm viability by developmental stage at which treatment was administered: (a) pairwise comparisons of proportion of females in each treatment that successfully mated, and (b) proportion of viable sperm stored in spermatheca on day 12 of adulthood
Summarized unreduced models for individuals treated as either juveniles or adults
| Fixed effect | Sperm viability | Egg viability | ||
|---|---|---|---|---|
| χ2 |
| χ2 |
| |
| Age | 3.94 | <.05 | 0.787 | .375 |
| Treatment | 0.01 | .910 | 0.192 | .661 |
| Age × Treatment | 1.68 | .195 | 4.05 | .133 |
FIGURE 3Fecundity and egg viability: (a) pairwise comparisons of total eggs contained produced by day 12 of adulthood for individuals that received their treatment at the developmental stages listed, and (b) proportion of viable eggs 10 days post‐oviposition for individuals that received their treatment as either juveniles or adults